CAS 1235712-40-9

Formula: C8H11N3O4S

InChI: InChI=1S/C8H11N3O4S/c9-5-1-2-11(8(13)10-5)6-4-16(14)7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+,16?/m0/s1

InChI key: LJMQAXFNQNADRZ-AOAOFLDXSA-N

SMILES: C1[C@H](O[C@H](S1=O)CO)N2C=CC(=NC2=O)N

Lamivudine S-oxide

CAS: 1235712-40-9

Lamivudine is an antiviral drug that belongs to the group of nucleoside analogues. It is a prodrug that is activated by intracellular phosphorylation to form the active compound, lamivudine triphosphate (L-TTP). L-TTP inhibits viral replication by competing with natural substrates for incorporation into viral DNA. The antiviral activity of L-TTP has been shown in animals and humans with hepatitis B virus or human immunodeficiency virus type 1 (HIV-1) infections. Lamivudine S-oxide is a stereoselective form of lamivudine, which can be used for chemoprophylaxis against the pandemic H1N1 virus. This drug has shown to have a lower toxicity profile than other drugs used for this purpose.

Formula: C₈H₁₁N₃O₄S

Purezza: Min. 95%

Peso molecolare: 245.26 g/mol

Ref: 3D-KZB71240

Lamivudine S-oxide

CAS: 1235712-40-9

Formula: C₈H₁₁N₃O₄S

Peso molecolare: 245.25

Ref: ST-EA-CP-L3018